Thomas E. Rohan

40.8k total citations · 2 hit papers
460 papers, 23.2k citations indexed

About

Thomas E. Rohan is a scholar working on Oncology, Cancer Research and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Thomas E. Rohan has authored 460 papers receiving a total of 23.2k indexed citations (citations by other indexed papers that have themselves been cited), including 257 papers in Oncology, 115 papers in Cancer Research and 113 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Thomas E. Rohan's work include Cancer Risks and Factors (188 papers), Nutritional Studies and Diet (93 papers) and Breast Cancer Treatment Studies (56 papers). Thomas E. Rohan is often cited by papers focused on Cancer Risks and Factors (188 papers), Nutritional Studies and Diet (93 papers) and Breast Cancer Treatment Studies (56 papers). Thomas E. Rohan collaborates with scholars based in United States, Canada and United Kingdom. Thomas E. Rohan's co-authors include Anthony B. Miller, Geoffrey C. Kabat, Paul Terry, Geoffrey R. Howe, Rowan T. Chlebowski, Stephanie A. Navarro Silvera, Eduardo L. Franco, Luisa L. Villa, JoAnn E. Manson and Meera Jain and has published in prestigious journals such as New England Journal of Medicine, The Lancet and JAMA.

In The Last Decade

Thomas E. Rohan

451 papers receiving 22.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dietary Factors and Risk of Breast Cancer: Combined Analysis of 12 Case--Control Studies

1990 589 citations Thomas E. Rohan et al. profile →
Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-term Follow-up of the Women’s Health Initiative Randomized Clinical Trials

2020 227 citations Rowan T. Chlebowski, Garnet L. Anderson et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas E. Rohan United States	83	9.1k	5.1k	4.7k	4.2k	4.1k	460	23.2k
Lynne R. Wilkens United States	78	5.5k 0.6×	5.2k 1.0×	6.2k 1.3×	2.6k 0.6×	3.0k 0.7×	546	22.7k
Rudolf Kaaks Germany	70	6.2k 0.7×	4.9k 1.0×	3.5k 0.7×	3.2k 0.8×	2.6k 0.6×	308	18.2k
Louise A. Brinton United States	91	12.2k 1.3×	4.0k 0.8×	4.9k 1.0×	5.7k 1.3×	4.8k 1.2×	446	29.4k
Wei Zheng United States	91	9.1k 1.0×	8.7k 1.7×	6.7k 1.4×	4.6k 1.1×	2.6k 0.6×	910	32.0k
Laurence N. Kolonel United States	90	8.4k 0.9×	6.1k 1.2×	6.9k 1.5×	3.8k 0.9×	2.0k 0.5×	435	28.6k
Robert N. Hoover United States	96	10.1k 1.1×	5.3k 1.0×	4.0k 0.8×	4.6k 1.1×	2.5k 0.6×	381	29.7k
Andrew T. Chan United States	87	9.4k 1.0×	7.6k 1.5×	3.9k 0.8×	4.3k 1.0×	4.5k 1.1×	610	31.0k
Susanna C. Larsson Sweden	84	4.4k 0.5×	4.6k 0.9×	5.5k 1.2×	2.2k 0.5×	3.3k 0.8×	460	25.0k
Cristina Bosetti Italy	80	6.3k 0.7×	3.8k 0.7×	3.7k 0.8×	3.0k 0.7×	3.0k 0.7×	368	21.1k
Demetrius Albanes United States	88	5.0k 0.6×	6.2k 1.2×	6.0k 1.3×	3.8k 0.9×	2.2k 0.5×	462	25.2k

Countries citing papers authored by Thomas E. Rohan

Since Specialization

Citations

This map shows the geographic impact of Thomas E. Rohan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Rohan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Rohan more than expected).

Fields of papers citing papers by Thomas E. Rohan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas E. Rohan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Rohan. The network helps show where Thomas E. Rohan may publish in the future.

Co-authorship network of co-authors of Thomas E. Rohan

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas E. Rohan. A scholar is included among the top collaborators of Thomas E. Rohan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas E. Rohan. Thomas E. Rohan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Blew, Robert M., Denise J. Roe, Andrew Odegaard, et al.. (2025). Dual-energy X-ray Absorptiometry–Derived Adiposity and Colorectal Cancer Incidence and Mortality in Postmenopausal Women. Cancer Epidemiology Biomarkers & Prevention. 34(10). 1801–1809.

Bea, Jennifer W., Heather M. Ochs‐Balcom, Zhao Chen, et al.. (2025). Abdominal visceral and subcutaneous adipose tissue associations with postmenopausal breast cancer incidence. JNCI Cancer Spectrum. 9(1). 2 indexed citations

Rohan, Thomas E., Fergus J. Couch, Robert T. Greenlee, et al.. (2025). p16, COX-2, and Ki67 Protein Expression in DCIS and Risk of Ipsilateral Invasive Breast Cancer. Cancer Epidemiology Biomarkers & Prevention. 34(6). 1036–1039.

Nelson, Rebecca A., Rowan T. Chlebowski, Kathy Pan, et al.. (2024). Breast Cancer Risk Assessment Tool (BCRAT) and long-term breast cancer mortality in the Women's Health Initiative. Breast Cancer Research and Treatment. 209(1). 49–60. 3 indexed citations

Peila, Rita, Xiaonan Xue, Michael J. LaMonte, et al.. (2023). Menopausal hormone therapy and change in physical activity in the Women's Health Initiative hormone therapy clinical trials. Menopause The Journal of The North American Menopause Society. 30(9). 898–905. 3 indexed citations

Peters, Brandilyn A., Libusha Kelly, Tao Wang, Olivier Loudig, & Thomas E. Rohan. (2023). The Breast Microbiome in Breast Cancer Risk and Progression: A Narrative Review. Cancer Epidemiology Biomarkers & Prevention. 33(1). 9–19. 7 indexed citations

Figueroa, Jonine D., Gretchen L. Gierach, Máire A. Duggan, et al.. (2021). Risk factors for breast cancer development by tumor characteristics among women with benign breast disease. Breast Cancer Research. 23(1). 34–34. 21 indexed citations

Reding, Kerryn W., Claire J. Han, Dale Whittington, et al.. (2020). Risk of Breast Cancer Associated with Estrogen DNA Adduct Biomarker. Cancer Epidemiology Biomarkers & Prevention. 29(10). 2096–2099. 2 indexed citations

Rohan, Thomas E., Tao Wang, Sheila Weinmann, et al.. (2019). A miRNA Expression Signature in Breast Tumor Tissue Is Associated with Risk of Distant Metastasis. Cancer Research. 79(7). 1705–1713. 13 indexed citations

10.

Liang, Xiaoyun, Karen L. Margolis, Michael Hendryx, et al.. (2017). Metabolic Phenotype and Risk of Colorectal Cancer in Normal-Weight Postmenopausal Women. Cancer Epidemiology Biomarkers & Prevention. 26(2). 155–161. 17 indexed citations

11.

Brinton, Louise A., Britton Trabert, Garnet L. Anderson, et al.. (2016). Serum Estrogens and Estrogen Metabolites and Endometrial Cancer Risk among Postmenopausal Women. Cancer Epidemiology Biomarkers & Prevention. 25(7). 1081–1089. 60 indexed citations

12.

Heo, Moonseong, Geoffrey C. Kabat, Howard D. Strickler, et al.. (2015). Optimal Cutoffs of Obesity Measures in Relation to Cancer Risk in Postmenopausal Women in the Women's Health Initiative Study. Journal of Women s Health. 24(3). 218–227. 15 indexed citations

13.

Thomson, Cynthia A., Linda Van Horn, Bette J. Caan, et al.. (2014). Cancer Incidence and Mortality during the Intervention and Postintervention Periods of the Women's Health Initiative Dietary Modification Trial. Cancer Epidemiology Biomarkers & Prevention. 23(12). 2924–2935. 41 indexed citations

14.

Kabat, Geoffrey C., Matthew L. Anderson, Moonseong Heo, et al.. (2013). Adult Stature and Risk of Cancer at Different Anatomic Sites in a Cohort of Postmenopausal Women. Cancer Epidemiology Biomarkers & Prevention. 22(8). 1353–1363. 44 indexed citations

15.

Ho, Gloria Y. F., Marc J. Gunter, Howard D. Strickler, et al.. (2012). Adipokines Linking Obesity with Colorectal Cancer Risk in Postmenopausal Women. Cancer Research. 72(12). 3029–3037. 118 indexed citations

16.

Hutter, Carolyn M., Alicia Young, Heather M. Ochs‐Balcom, et al.. (2011). Replication of Breast Cancer GWAS Susceptibility Loci in the Women's Health Initiative African American SHARe Study. Cancer Epidemiology Biomarkers & Prevention. 20(9). 1950–1959. 48 indexed citations

17.

Robinson, Brian D., Gabriel Sica, Thomas E. Rohan, et al.. (2009). Tumor Microenvironment of Metastasis in Human Breast Carcinoma: A Potential Prognostic Marker Linked to Hematogenous Dissemination. Clinical Cancer Research. 15(7). 2433–2441. 260 indexed citations

18.

Trottier, Helen, Salaheddin M. Mahmud, Cecília Costa, et al.. (2006). Human Papillomavirus Infections with Multiple Types and Risk of Cervical Neoplasia. Cancer Epidemiology Biomarkers & Prevention. 15(7). 1274–1280. 280 indexed citations

19.

Rohan, Thomas E., et al.. (2002). Cancer precursors : epidemiology, detection, and prevention. CERN Document Server (European Organization for Nuclear Research). 43 indexed citations

20.

Rousseau, Marie, et al.. (2000). A cumulative case-control study of risk factor profiles for oncogenic and nononcogenic cervical human papillomavirus infections.. EspaceINRS (National Institute for Scientific Research (Canada)). 9(5). 469–76. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact